Regeneron Announces Prelim. Data In An ASGCT Presentation Showing DB-OTO Improved Hearing To Normal Levels In One Child Within 24 Weeks, Initial Hearing Improvements Observed In A Second Child At 6-Week Assessment
Regeneron Announces Prelim. Data In An ASGCT Presentation Showing DB-OTO Improved Hearing To Normal Levels In One Child Within 24 Weeks, Initial Hearing Improvements Observed In A Second Child At 6-Week Assessment
Regeneron 宣佈預賽。ASGCT 演示中的數據顯示，DB-OTO 在 24 周內將一個孩子的聽力改善到正常水平，在 6 周評估中觀察到第二個孩子的初次聽力改善
Regeneron Announces Prelim. Data In An ASGCT Presentation Showing DB-OTO Improved Hearing To Normal Levels In One Child Within 24 Weeks, Initial Hearing Improvements Observed In A Second Child At 6-Week Assessment
Regeneron 宣佈預賽。ASGCT 演示中的數據顯示，DB-OTO 在 24 周內將一個孩子的聽力改善到正常水平，在 6 周評估中觀察到第二個孩子的初次聽力改善